{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:02:11Z","timestamp":1788577331535,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515140069"],"award-info":[{"award-number":["2021B1515140069"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0090\/2022\/A"],"award-info":[{"award-number":["0090\/2022\/A"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0116\/2023\/RIA2"],"award-info":[{"award-number":["0116\/2023\/RIA2"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103358"],"award-info":[{"award-number":["82103358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373166"],"award-info":[{"award-number":["82373166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072813"],"award-info":[{"award-number":["82072813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbadis.2025.167722","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T09:25:36Z","timestamp":1739784336000},"page":"167722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer"],"prefix":"10.1016","volume":"1871","author":[{"given":"Yaqiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weide","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0005","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1080\/21655979.2022.2037367","article-title":"Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer","volume":"13","author":"Ding","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41698-024-00503-2","article-title":"A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cpt.2023.04.003","article-title":"Chimeric RNAs and their implication in prostate cancer","volume":"1","author":"Li","year":"2023","journal-title":"Cancer Pathog Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13046-023-02774-2","article-title":"LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a\/RREB1 positive feedback loop and a ceRNA network","volume":"42","author":"Dong","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.21873\/invivo.12703","article-title":"Stereotactic radiotherapy and androgen deprivation therapy for localized prostate cancer: a retrospective mono-institutional experience","volume":"36","author":"Magli","year":"2022","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167722_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12094-021-02727-1","article-title":"Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function","volume":"24","author":"Reiss","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167722_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41585-021-00514-9","article-title":"Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer","volume":"18","author":"Devos","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"23","key":"10.1016\/j.bbadis.2025.167722_bb0040","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2004325","article-title":"Oral Relugolix for androgen-deprivation therapy in advanced prostate cancer","volume":"382","author":"Shore","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/21691401.2019.1703726","article-title":"Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles","volume":"48","author":"Liu","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167722_bb0050","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S1470-2045(19)30486-3","article-title":"Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial","volume":"20","author":"Carrie","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030295","article-title":"Pharmacometabolomics applied to personalized medicine in urological cancers","volume":"15","author":"Amaro","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.bbadis.2025.167722_bb0060","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.275.10.7189","article-title":"Myeloid leukemia cell growth and differentiation are independent of mitogen-activated protein kinase ERK1\/2 activation","volume":"275","author":"Ajenjo","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167722_bb0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0000000000000964","article-title":"Interleukin-15 in kidney disease and therapeutics","volume":"33","author":"Hall","year":"2024","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12957-020-01817-8","article-title":"CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis","volume":"18","author":"Li","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2025.167722_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12957-015-0746-8","article-title":"Expression and significance of CD44 and p-AKT in pancreatic head cancer","volume":"13","author":"Xiaoping","year":"2015","journal-title":"World J. Surg. Oncol."},{"issue":"15","key":"10.1016\/j.bbadis.2025.167722_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153644","article-title":"Presence of concurrent TP53 mutations is necessary to predict poor outcomes within the SMAD4 mutated subgroup of metastatic colorectal Cancer","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2025.167722_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.omto.2020.09.011","article-title":"Prognostic implication of a metabolism-associated gene signature in lung adenocarcinoma","volume":"19","author":"He","year":"2020","journal-title":"Mol Ther Oncolytics."},{"issue":"10","key":"10.1016\/j.bbadis.2025.167722_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101649","article-title":"CRISPR\/Cas9 delivery system engineering for genome editing in therapeutic applications","volume":"13","author":"Cheng","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbadis.2025.167722_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/230183","article-title":"CC chemokine ligand 18 correlates with malignant progression of prostate cancer","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167722_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122862","article-title":"Mitochondrial dysfunction and the glycolytic switch induced by Caveolin-1 phosphorylation promote Cancer cell migration, invasion, and metastasis","volume":"14","author":"Diaz-Valdivia","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12957-021-02479-w","article-title":"High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma","volume":"20","author":"Mu","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"16","key":"10.1016\/j.bbadis.2025.167722_bb0110","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1073\/pnas.1007694108","article-title":"AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma","volume":"108","author":"Namiki","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2025.167722_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.944000","article-title":"Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167722_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14712598.2022.2027904","article-title":"Prostate cancer immunotherapy","volume":"22","author":"Mitsogiannis","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167722_bb0125","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-16-2569","article-title":"Immunotherapy for breast Cancer: what are we missing?","volume":"23","author":"Vonderheide","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167722_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.690188","article-title":"Abscopal effects of local radiotherapy are dependent on tumor immunogenicity","volume":"11","author":"Lai","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2025.167722_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41525-018-0051-x","article-title":"Mutation load estimation model as a predictor of the response to cancer immunotherapy","volume":"3","author":"Lyu","year":"2018","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.bbadis.2025.167722_bb0140","article-title":"TMBcat: a multi-endpoint p-value criterion on different discrepancy metrics for superiorly inferring tumor mutation burden thresholds","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbadis.2025.167722_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002032","article-title":"A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery","volume":"9","author":"Creemers","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"18","key":"10.1016\/j.bbadis.2025.167722_bb0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1089\/scd.2021.0043","article-title":"Reduced DAPK1 expression promotes stem cell-like characteristics of prostate Cancer cells by activating ZEB1 via hippo\/YAP signaling pathway","volume":"30","author":"Nong","year":"2021","journal-title":"Stem Cells Dev."},{"issue":"6","key":"10.1016\/j.bbadis.2025.167722_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211016624","article-title":"Identification of crucial genes and pathways associated with prostate cancer in multiple databases","volume":"49","author":"Guo","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"14","key":"10.1016\/j.bbadis.2025.167722_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019628","article-title":"Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2017.191","article-title":"Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer","volume":"117","author":"Goto","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2025.167722_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12894-015-0085-7","article-title":"Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer","volume":"15","author":"Zeng","year":"2015","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bbrc.2014.06.007","article-title":"Eph receptor A10 has a potential as a target for a prostate cancer therapy","volume":"450","author":"Nagano","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.bbadis.2025.167722_bb0180","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/0008-5472.CAN-13-0443","article-title":"PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer","volume":"73","author":"Zheng","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167722_bb0185","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1349-7006.2009.01277.x","article-title":"Overexpression of the potential kinase serine\/ threonine\/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer","volume":"100","author":"Chung","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2025.167722_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.01.106","article-title":"TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK\/GSK3beta\/SNAIL pathway","volume":"546","author":"Zhang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111669","article-title":"Silencing TTK expression inhibits the proliferation and progression of prostate cancer","volume":"385","author":"Chen","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167722_bb0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00109-012-0949-1","article-title":"The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer","volume":"91","author":"Kuner","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"issue":"36","key":"10.1016\/j.bbadis.2025.167722_bb0205","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1038\/s41388-019-0880-9","article-title":"Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A\/BIM signaling in a double-transgenic mouse model","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.32530","article-title":"FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming","volume":"146","author":"Zhang","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbadis.2025.167722_bb0215","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/mc.22982","article-title":"NEK5 promotes breast cancer cell proliferation through up-regulation of cyclin A2","volume":"58","author":"Pei","year":"2019","journal-title":"Mol. Carcinog."},{"issue":"38","key":"10.1016\/j.bbadis.2025.167722_bb0220","doi-asserted-by":"crossref","first-page":"61366","DOI":"10.18632\/oncotarget.11351","article-title":"Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0225","first-page":"17","article-title":"The NEK family of serine\/threonine kinases as a biomarker for cancer","volume":"23","author":"Panchal","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"9","key":"10.1016\/j.bbadis.2025.167722_bb0230","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/mrd.23234","article-title":"NEK5 regulates cell cycle progression during mouse oocyte maturation and preimplantation embryonic development","volume":"86","author":"Li","year":"2019","journal-title":"Mol. Reprod. Dev."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1083\/jcb.201412099","article-title":"Nek5 promotes centrosome integrity in interphase and loss of centrosome cohesion in mitosis","volume":"209","author":"Prosser","year":"2015","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.167722_bb0240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12672-010-0060-4","article-title":"Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects","volume":"2","author":"Fukasawa","year":"2011","journal-title":"Horm Cancer."},{"issue":"16","key":"10.1016\/j.bbadis.2025.167722_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169325","article-title":"Identification and validation of TRIM25 as a glucose metabolism regulator in prostate Cancer","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5930","key":"10.1016\/j.bbadis.2025.167722_bb0250","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"3191","key":"10.1016\/j.bbadis.2025.167722_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbadis.2025.167722_bb0260","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12885-023-10685-w","article-title":"NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling","volume":"23","author":"Ma","year":"2023","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.bbadis.2025.167722_bb0265","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41422-019-0181-4","article-title":"AIF-regulated oxidative phosphorylation supports lung cancer development","volume":"29","author":"Rao","year":"2019","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.bbadis.2025.167722_bb0270","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.18632\/oncotarget.2010","article-title":"Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation","volume":"5","author":"Pasto","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbadis.2025.167722_bb0275","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.cell.2020.07.039","article-title":"Oxidative metabolism drives immortalization of neural stem cells during tumorigenesis","volume":"182","author":"Bonnay","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0280","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/1570159X20666220810114644","article-title":"mtDNA maintenance and alterations in the pathogenesis of neurodegenerative diseases","volume":"21","author":"Shang","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbadis.2025.167722_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2019.03.008","article-title":"HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia\/reperfusion injury","volume":"130","author":"Yang","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bbadis.2025.167722_bb0290","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2025.167722_bb0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mito.2006.11.026","article-title":"Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage","volume":"7","author":"Indo","year":"2007","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.bbadis.2025.167722_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051329","article-title":"TOM40 inhibits ovarian Cancer cell growth by modulating mitochondrial function including intracellular ATP and ROS levels","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"11","key":"10.1016\/j.bbadis.2025.167722_bb0305","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1158\/0008-5472.CAN-19-2852","article-title":"GPD1 enhances the anticancer effects of metformin by synergistically increasing total cellular glycerol-3-phosphate","volume":"80","author":"Xie","year":"2020","journal-title":"Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:09:46Z","timestamp":1778551786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0925443925000675"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167722","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167722"}}